Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Pentoxifylline Administration on the Modulation of Hyporesponsiveness to Erythropoietin Stimulating Agents in Hemodialysis Patients

NCT03800433 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT03800433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03800433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Pentoxifylline Administration on the Modulation of Hyporesponsiveness to Erythropoietin Stimulating Agents in Hemodialysis Patients
Lead sponsor
Ain Shams University
Phase
Phase 1
Overall status
Unknown status
Start date
October 31, 2019
Completion date
April 30, 2020
Enrollment
46 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia renal